Manfred Windisch

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Nature medicine

PloS one

NeuroScios GmbH

Karl-Franzens-Universität Graz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NeuroScios GmbH Aug 29 2013

Austria

Vice President :: Clinical Pharmacology

JSW Lifesciences GmbH Jul 31 1999

Austria

CEO :: Research and development

Education History

Karl-Franzens-Universität Graz Oct 01 1975 - Jun 15 1985

Austria

PHD :: Physiology

Publications

Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Mirsada Causevic, Kristina Dominko, Martina Malnar, Lea Vidatic, Stjepko Cermak, Martina Pigoni, Peer-Hendrik Kuhn, Alessio Colombo, Daniel Havas, Stefanie Flunkert, Jessica McDonald, Jenny M Gunnersen, Birgit Hutter-Paier, Sabina Tahirovic, Manfred Windisch, Dimitri Krainc, Stefan F Lichtenthaler, Silva Hecimovic
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains. PloS one 13 (7) (2018)

Manfred Windisch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Manfred Windisch